CN103113308A - Method for preparing dihydropyrimidinone derivative - Google Patents
Method for preparing dihydropyrimidinone derivative Download PDFInfo
- Publication number
- CN103113308A CN103113308A CN2013100291676A CN201310029167A CN103113308A CN 103113308 A CN103113308 A CN 103113308A CN 2013100291676 A CN2013100291676 A CN 2013100291676A CN 201310029167 A CN201310029167 A CN 201310029167A CN 103113308 A CN103113308 A CN 103113308A
- Authority
- CN
- China
- Prior art keywords
- dihydropyrimidinone
- preparing
- aldehyde
- iodine
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QGKGASXQTBQINX-UHFFFAOYSA-N 3,4-dihydro-1h-pyrimidin-2-one Chemical class O=C1NCC=CN1 QGKGASXQTBQINX-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 11
- 239000011630 iodine Substances 0.000 claims abstract description 11
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 238000010992 reflux Methods 0.000 claims abstract description 8
- 150000003934 aromatic aldehydes Chemical class 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims abstract description 3
- 150000002192 fatty aldehydes Chemical class 0.000 claims abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- -1 aliphatic aldehyde Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 230000004071 biological effect Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000004202 carbamide Substances 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methyl urea Chemical compound CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 8
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940100595 phenylacetaldehyde Drugs 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- LOBCDGHHHHGHFA-LBPRGKRZSA-N (S)-monastrol Chemical compound CCOC(=O)C1=C(C)NC(=S)N[C@H]1C1=CC=CC(O)=C1 LOBCDGHHHHGHFA-LBPRGKRZSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种制备二氢嘧啶酮衍生物的方法。 The invention relates to a method for preparing dihydropyrimidinone derivatives.
背景技术 Background technique
二氢嘧啶酮衍生物是一种具有重要生物活性的杂环分子,可以作为精细化工产品和医药的重要中间体;研究已经发现二氢嘧啶酮衍生物具有众多药理活性,参见(Eur. J. Med. Chem. 2000, 35, 1043; Science, 1999, 286, 971; J. Med.Chem., 1995, 38, 119; Molecules 2000, 5, 227; Molecules 1998, 3, 1; Eur.J. Med. Chem. 2010, 45, 367)。其中已经发展成药物的例子是(S)-Monastrol, (S)-L-771688 和 (S)-SQ 32926等,参见(Chem. Biol., 2002, 9, 989; J. Med. Chem., 2000, 43, 2703; Nat. Med.,2002, 8, 825; J.Med. Chem., 1991, 34, 806.)。 Dihydropyrimidone derivatives are heterocyclic molecules with important biological activities, which can be used as important intermediates in fine chemical products and medicines; studies have found that dihydropyrimidone derivatives have many pharmacological activities, see ( Eur. J. Med. Chem. 2000 , 35 , 1043; Science , 1999 , 286 , 971; J. Med. Chem. , 1995 , 38 , 119; Molecules 2000 , 5 , 227; Molecules 1998 , 3 , 1 ; . Chem. 2010 , 45 , 367). Examples of which have been developed into drugs are ( S )-Monastrol, ( S )-L-771688 and ( S )-SQ 32926, etc., see ( Chem. Biol ., 2002, 9 , 989; J. Med. Chem. , 2000, 43 , 2703; Nat. Med. , 2002, 8 , 825; J. Med. Chem. , 1991, 34 , 806.).
以乙酰乙酸酯、醛和脲为原料,通过Biginelli方法合成二氢嘧啶酮衍生物是最经典的(Gazz. Chim. Ital. 1893, 23, 360), 最近有取多文献报道了许多用其它含活泼亚甲基化合物代替乙酰乙酸酯参与Biginelli类型的反应制备新型二氢嘧啶酮衍生物衍生物,参见(Tetrahedron Lett. 2003, 44, 4559; Tetrahedron Lett. 2004, 45, 7951; Helv. Chim. Acta 2005, 88, 2996; Tetrahedron 2007, 63, 1981; Tetrahedron Lett. 2009, 50, 1622; Chem. Commun. 2007, 2932; J. Org. Chem. 2009, 74, 3141; Chem. Commun. 2009, 2768)。由于多取代的二氢嘧啶酮衍生物的拥有较高的生物活性,而且经常能作为有机合成的重要中间体,因此进一步开发新型二氢嘧啶酮衍生物的高效的制备方法,对新药筛选等有重要意义。 Using acetoacetate, aldehyde and urea as raw materials, the synthesis of dihydropyrimidinone derivatives by the Biginelli method is the most classic ( Gazz. Chim. Ital. 1893 , 23 , 360 ). Active methylene compounds instead of acetoacetate participate in Biginelli-type reactions to prepare novel dihydropyrimidinone derivatives, see ( Tetrahedron Lett. 2003 , 44 , 4559; Tetrahedron Lett. 2004 , 45 , 7951; Helv. Chim . Acta 2005 , 88 , 2996; Tetrahedron 2007 , 63 , 1981; Tetrahedron Lett. 2009 , 50 , 1622; Chem . Commun. 2007 , 2932 ; J. Org . Chem. 2768). Since the multi-substituted dihydropyrimidinone derivatives have high biological activity and can often be used as important intermediates in organic synthesis, further development of efficient preparation methods for novel dihydropyrimidinone derivatives will be useful for new drug screening and the like. Significance.
发明内容 Contents of the invention
本发明的目的是提供一种反应温和、操作简便的制备二氢嘧啶酮衍生物的方法。 The object of the present invention is to provide a method for preparing dihydropyrimidinone derivatives with mild reaction and easy operation.
本发明的制备二氢嘧啶酮衍生物的方法,其制备过程是以以碘为催化剂,在有机溶剂中先使1-烷基脲和芳香醛在室温下搅拌反应30分钟,然后加入脂肪醛搅拌回流反应5~15小时,经过纯化过程得到二氢嘧啶酮衍生物,所说的1-烷基脲、芳香醛、脂肪醛和碘之间的摩尔比为1:1~1.5:1:0.01~0.1; In the method for preparing dihydropyrimidinone derivatives of the present invention, the preparation process is to use iodine as a catalyst, first make 1-alkylurea and aromatic aldehyde stir and react at room temperature for 30 minutes in an organic solvent, and then add aliphatic aldehyde and stir Refluxing reaction for 5-15 hours, after purification process to obtain dihydropyrimidinone derivatives, the molar ratio between said 1-alkylurea, aromatic aldehyde, fatty aldehyde and iodine is 1:1~1.5:1:0.01~ 0.1;
反应式为: The reaction formula is:
; ;
式中:R1选自C1~C4的烷基, R2选自C1~C8的烷基或芳基,R3选自H、卤素、硝基、氰基、三氟甲基、C1~C4的烷基或C1~C4的烷氧基。所述的有机溶剂是乙腈、四氢呋喃、甲苯、二甲苯、1,2-二氯乙烷或1,4-二氧六环。 In the formula: R 1 is selected from C 1 ~ C 4 alkyl, R 2 is selected from C 1 ~ C 8 alkyl or aryl, R 3 is selected from H, halogen, nitro, cyano, trifluoromethyl , C 1 -C 4 alkyl or C 1 -C 4 alkoxy. The organic solvent is acetonitrile, tetrahydrofuran, toluene, xylene, 1,2-dichloroethane or 1,4-dioxane.
本发明与已有的合成方法相比,具有以下优点: Compared with existing synthetic methods, the present invention has the following advantages:
1)反应条件温和; 1) Mild reaction conditions;
2)反应通用性强; 2) Strong versatility of response;
3)投料和后处理都非常简单; 3) Feeding and post-processing are very simple;
4) 不需要金属催化,采用碘催化能兼容更多的取代基,尤其是酸敏性的基团。 4) It does not require metal catalysis, and the use of iodine catalysis can accommodate more substituents, especially acid-sensitive groups.
具体实施方法 Specific implementation method
以下实施例将有助于理解本发明,但不限于本发明的内容: The following examples will help to understand the present invention, but are not limited to the content of the present invention:
实施例1 Example 1
把对硝基苯甲醛(15毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于乙腈(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应10小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-硝基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率72%;产物物理数据为熔点186-188 oC; IR(neat) ν3250, 1682, 1651, 1519, 1497, 1455, 1403, 1270, 818, 736, 732, 700 cm-1; 1H NMR (400 MHz, CDCl3) δ =8.13 (d, J = 8.7 Hz, 2 H), 7.46 (d, J = 8.7 Hz, 2 H), 7.26-7.12 (m, 5 H), 6.55 (s, 1 H), 6.14 (s, 1 H), 5.60 (d, J = 2.6 Hz, 1 H), 3.20 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ= 153.24, 149.21, 147.53, 135.30, 128.78, 127.95, 127.65, 127.06, 124.86, 124.21, 112.81, 57.34, 34.79 ppm. HRMS (EI): m/z calcd for (C17H15N3O3): 309.1113; found: 309.1111。 Dissolve p-nitrobenzaldehyde (15 mmoles), 1-methylurea (10 mmoles) and iodine (1 mmoles) in acetonitrile (20 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 10 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-methyl-4-(4-nitrophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a yellow solid in 72% yield; product physical data Melting point 186-188 o C; IR(neat) ν 3250, 1682, 1651, 1519, 1497, 1455, 1403, 1270, 818, 736, 732, 700 cm -1 ; 1 H NMR (400 MHz, CDCl 3 ) δ =8.13 (d, J = 8.7 Hz, 2 H), 7.46 (d, J = 8.7 Hz, 2 H), 7.26-7.12 (m, 5 H), 6.55 (s, 1 H), 6.14 (s, 1 H), 5.60 (d, J = 2.6 Hz, 1 H), 3.20 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ= 153.24, 149.21, 147.53, 135.30, 128.78, 127.95, 127.65, 127.06, 124.86, 124.21, 112.81, 57.34, 34.79 ppm. HRMS (EI): m/z calcd for (C 17 H 15 N 3 O 3 ): 309.1113; found: 309.1111.
实施例2 Example 2
把对氰基苯甲醛(12毫摩尔)、1-甲基脲(10毫摩尔) 和碘(0.8毫摩尔)溶解于乙腈(15毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得白色固体的1-甲基-4-(4-氰基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率68%;产物物理数据为熔点113-115 oC,IR(neat) ν3249, 2925, 2228, 1679, 1603, 1498, 1456, 1404, 1327, 1269, 1108, 765, 731, 694, 587 cm-1;1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 7.2 Hz, 2 H), 7.38 (d, J = 7.9 Hz, 2 H), 7.26-7.19 (m, 2 H), 7.14 (dd, J = 17.6, 7.4 Hz, 3 H), 6.53 (s, 1 H), 6.08 (br, 1 H), 5.52 (s, 1 H), 3.17 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 153.26, 147.33, 135.37, 132.72, 128.72, 127.90, 127.47, 126.96, 124.81, 118.44, 112.77, 111.83, 57.50, 34.72 ppm. HRMS (EI): m/z calcd for (C18H15N3O): 289.1215; found: 289.1225。 Dissolve p-cyanobenzaldehyde (12 mmoles), 1-methylurea (10 mmoles) and iodine (0.8 mmoles) in acetonitrile (15 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-methyl-4-(4-cyanophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a white solid in a yield of 68%; product physical data IR(neat) ν 3249, 2925 , 2228, 1679, 1603, 1498, 1456, 1404, 1327, 1269, 1108, 765, 731, 694, 587 cm -1 ; 1 H NMR ( 400 MHz, CDCl 3 ) δ 7.55 (d, J = 7.2 Hz, 2 H), 7.38 (d, J = 7.9 Hz, 2 H), 7.26-7.19 (m, 2 H), 7.14 (dd, J = 17.6 , 7.4 Hz, 3 H), 6.53 (s, 1 H), 6.08 (br, 1 H), 5.52 (s, 1 H), 3.17 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 153.26, 147.33, 135.37, 132.72, 128.72, 127.90, 127.47, 126.96, 124.81, 118.44, 112.77, 111.83 , 57.50, 34.72 ppm. : 289.1215; found: 289.1225.
实施例3 Example 3
把对溴苯甲醛(10毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于甲苯(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-溴苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率58%;产物物理数据为熔点170-172 oC; IR(neat) ν3265, 1673, 1485, 1455, 1405, 1325, 1266, 1003, 754, 730, 694 cm-1; 1H NMR (400 MHz, CDCl3) δ =7.41 (d, J = 8.3 Hz, 2 H), 7.25-7.19 (m, 2 H), 7.15 (t, J = 7.8 Hz, 5 H), 6.52 (s, 1 H), 5.56 (s, 1 H), 5.43 (d, J = 2.1 Hz, 1 H), 3.19 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ =153.29, 141.39, 135.71, 132.00, 128.59, 128.47, 127.51, 126.75, 124.85, 121.93, 113.30, 57.46, 34.69 ppm. HRMS (EI): m/z calcd for (C17H15BrN2O): 342.0368; found: 340.0211。 Dissolve p-bromobenzaldehyde (10 mmol), 1-methylurea (10 mmol) and iodine (1 mmol) in toluene (20 ml), stir the reaction for 30 minutes, then add phenylacetaldehyde (10 mmol mol), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, the concentrated mixture was purified by silica gel column chromatography, 1-Methyl-4-(4-bromophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one was obtained as a yellow solid in a yield of 58%; the physical data of the product are melting points 170-172 o C; IR(neat) ν 3265, 1673, 1485, 1455, 1405, 1325, 1266, 1003, 754, 730, 694 cm -1 ; 1 H NMR (400 MHz, CDCl 3 ) δ =7.41 ( d, J = 8.3 Hz, 2 H), 7.25-7.19 (m, 2 H), 7.15 (t, J = 7.8 Hz, 5 H), 6.52 (s, 1 H), 5.56 (s, 1 H), 5.43 (d, J = 2.1 Hz, 1 H), 3.19 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ =153.29, 141.39, 135.71, 132.00, 128.59, 128.47, 127.51, 126.75, 124.85, 121.93, 113.30, 57.46, 34.69 ppm. HRMS (EI): m/z calcd for (C 17 H 15 BrN 2 O): 342.0368; found: 340.0211.
实施例4 Example 4
把对硝基苯甲醛(15毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于二氯乙烷(20毫升),充分搅拌反应30分钟之后,加入正己醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-硝基苯基)-5-丁基-3,4-二氢嘧啶-2(1氢)-酮,产率65%;产物物理数据为熔点121-123 oC;IR (neat) ν3258, 2956, 2929, 2869, 1673, 1596, 1520, 1465, 1396, 1346, 1310, 1268, 1108, 1036, 855, 754, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 8.6 Hz, 2 H), 7.45 (d, J = 8.6 Hz, 2 H), 5.80 (s, 1 H), 5.37 (s, 1 H), 5.02 (s, 1 H), 3.07 (s, 3 H), 1.72 (d, J = 4.5 Hz, 2 H), 1.35-1.18 (m, 4 H), 0.83 (t, J = 6.9 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 153.20, 149.87, 147.61, 127.81, 125.17, 124.05, 112.71, 58.95, 34.27, 29.88, 29.14, 22.10, 13.74 ppm. HRMS (EI): m/z calcd for (C15H19N3O3): 289.1426; found: 289.1421。 Dissolve p-nitrobenzaldehyde (15 mmol), 1-methylurea (10 mmol) and iodine (1 mmol) in dichloroethane (20 ml), stir the reaction for 30 minutes, then add n-hexanal (10 mmol), heated to reflux reaction for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was passed through a silica gel column layer Analysis and purification, 1-methyl-4-(4-nitrophenyl)-5-butyl-3,4-dihydropyrimidin-2(1hydrogen)-one was obtained as a yellow solid with a yield of 65%; the product Physical data are melting point 121-123 o C; IR (neat) ν 3258, 2956, 2929, 2869, 1673, 1596, 1520, 1465, 1396, 1346, 1310, 1268, 1108, 1036, 855, 754, 697 cm - 1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 8.19 (d, J = 8.6 Hz, 2 H), 7.45 (d, J = 8.6 Hz, 2 H), 5.80 (s, 1 H), 5.37 (s , 1 H), 5.02 (s, 1 H), 3.07 (s, 3 H), 1.72 (d, J = 4.5 Hz, 2 H), 1.35-1.18 (m, 4 H), 0.83 (t, J = 6.9 Hz, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 153.20, 149.87, 147.61, 127.81, 125.17, 124.05, 112.71, 58.95, 34.27, 29.88, 29.14, 213.10 ppm MS : m/z calcd for (C 15 H 19 N 3 O 3 ): 289.1426; found: 289.1421.
实施例5 Example 5
把对硝基苯甲醛(11毫摩尔)、1-乙基脲(10毫摩尔) 和碘(1毫摩尔)溶解于乙腈(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-乙基-4-(4-硝基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率69%;产物物理数据为熔点182-184 oC;IR (neat) ν3299, 2932, 1678, 1598, 1520, 1497, 1453, 1347, 1271, 1236, 1121, 817, 757, 731, 699 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8.4 Hz, 2 H), 7.46 (d, J = 8.4 Hz, 2 H), 7.24 (d, J = 7.4 Hz, 2 H), 7.17 (m, 3 H), 6.58 (s, 1 H), 5.97 (s, 1 H), 5.58 (s, 1 H), 3.63 (m, 2 H), 1.27 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 152.75, 149.32, 147.49, 135.46, 128.75, 127.61, 126.99, 126.53, 124.80, 113.05, 57.12, 42.17, 14.43 ppm. HRMS (EI): m/z calcd for (C18H17N3O3): 323.1270; found: 323.1270。 Dissolve p-nitrobenzaldehyde (11 mmoles), 1-ethylurea (10 mmoles) and iodine (1 mmoles) in acetonitrile (20 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-ethyl-4-(4-nitrophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a yellow solid in a yield of 69%; product physical data IR ( neat ) ν 3299, 2932, 1678, 1598, 1520, 1497, 1453, 1347, 1271, 1236, 1121, 817, 757, 731, 699 cm -1 ; 1 H NMR ( 400 MHz, CDCl 3 ) δ 8.14 (d, J = 8.4 Hz, 2 H), 7.46 (d, J = 8.4 Hz, 2 H), 7.24 (d, J = 7.4 Hz, 2 H), 7.17 (m, 3 H), 6.58 (s, 1 H), 5.97 (s, 1 H), 5.58 (s, 1 H), 3.63 (m, 2 H), 1.27 (t, J = 7.1 Hz, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 152.75, 149.32, 147.49, 135.46, 128.75, 127.61, 126.99, 126.53, 124.80, 113.05, 57.12, 42.17, 14.43 ppm for m (dMS/zEpm) 18 H 17 N 3 O 3 ): 323.1270; found: 323.1270.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310029167.6A CN103113308B (en) | 2013-01-25 | 2013-01-25 | A method for preparing dihydropyrimidinone derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310029167.6A CN103113308B (en) | 2013-01-25 | 2013-01-25 | A method for preparing dihydropyrimidinone derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103113308A true CN103113308A (en) | 2013-05-22 |
CN103113308B CN103113308B (en) | 2014-11-19 |
Family
ID=48411727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310029167.6A Expired - Fee Related CN103113308B (en) | 2013-01-25 | 2013-01-25 | A method for preparing dihydropyrimidinone derivatives |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103113308B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153240A (en) * | 2015-10-08 | 2015-12-16 | 齐鲁工业大学 | Research of pyridine oxadiazole complex in catalyzing dihydropyrimidones |
CN105233870A (en) * | 2015-09-24 | 2016-01-13 | 齐鲁工业大学 | Pyridine ethylene coordination polymers capable of catalyzing dihydropyrimidinones synthesis |
CN110041231A (en) * | 2019-05-21 | 2019-07-23 | 东华理工大学 | A kind of preparation method of N, O- acetal compound |
CN110551089A (en) * | 2018-05-31 | 2019-12-10 | 中国科学院上海有机化学研究所 | Preparation method of (R) - (-) -massoialactone |
TWI690515B (en) * | 2014-12-12 | 2020-04-11 | 日商日本煙草產業股份有限公司 | Dihydropyrimidin-2-one compound and pharmaceutical use thereof |
US10899717B2 (en) | 2018-02-28 | 2021-01-26 | Japan Tobacco Inc. | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107501416A (en) * | 2017-08-25 | 2017-12-22 | 东华大学 | A kind of method that cellulose dihydropyrimidinone derivative is prepared based on multicomponent click chemistry |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101323597A (en) * | 2007-06-11 | 2008-12-17 | 安徽省庆云医药化工有限公司 | Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde |
CN102408380A (en) * | 2011-12-22 | 2012-04-11 | 浙江大学 | 5-aminopyrimidinethione compound and its preparation method |
-
2013
- 2013-01-25 CN CN201310029167.6A patent/CN103113308B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101323597A (en) * | 2007-06-11 | 2008-12-17 | 安徽省庆云医药化工有限公司 | Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde |
CN102408380A (en) * | 2011-12-22 | 2012-04-11 | 浙江大学 | 5-aminopyrimidinethione compound and its preparation method |
Non-Patent Citations (1)
Title |
---|
ZHI-LIANG SHEN,等: "《Bronsted Base-Catalyzed One-Pot Three-Component Biginelli-Type Reaction: An Efficient Synthesis of 4,5,6-Triaryl-3,4- dihydropyrimidin-2(1H)-one and Mechanistic Study》", 《J. ORG. CHEM.》, vol. 75, no. 4, 19 January 2010 (2010-01-19), pages 1162 - 1167 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI690515B (en) * | 2014-12-12 | 2020-04-11 | 日商日本煙草產業股份有限公司 | Dihydropyrimidin-2-one compound and pharmaceutical use thereof |
TWI739206B (en) * | 2014-12-12 | 2021-09-11 | 日商日本煙草產業股份有限公司 | Dihydropyrimidin-2-one compound and pharmaceutical use thereof |
CN105233870A (en) * | 2015-09-24 | 2016-01-13 | 齐鲁工业大学 | Pyridine ethylene coordination polymers capable of catalyzing dihydropyrimidinones synthesis |
CN105153240A (en) * | 2015-10-08 | 2015-12-16 | 齐鲁工业大学 | Research of pyridine oxadiazole complex in catalyzing dihydropyrimidones |
US10899717B2 (en) | 2018-02-28 | 2021-01-26 | Japan Tobacco Inc. | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof |
CN110551089A (en) * | 2018-05-31 | 2019-12-10 | 中国科学院上海有机化学研究所 | Preparation method of (R) - (-) -massoialactone |
CN110551089B (en) * | 2018-05-31 | 2022-11-22 | 中国科学院上海有机化学研究所 | Preparation method of (R) - (-) -massoialactone |
CN110041231A (en) * | 2019-05-21 | 2019-07-23 | 东华理工大学 | A kind of preparation method of N, O- acetal compound |
CN110041231B (en) * | 2019-05-21 | 2021-04-09 | 东华理工大学 | A kind of preparation method of N,O-acetal compound |
Also Published As
Publication number | Publication date |
---|---|
CN103113308B (en) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103113308B (en) | A method for preparing dihydropyrimidinone derivatives | |
Galenko et al. | Fe (II)/Au (I) relay catalyzed propargylisoxazole to pyridine isomerization: Access to 6-halonicotinates | |
Mofakham et al. | Cellulose-SO3H as a biodegradable solid acid catalyzed one-pot three-component Ugi reaction: Synthesis of α-amino amide, 3, 4-dihydroquinoxalin-2-amine, 4H-benzo [b][1, 4] thiazin-2-amine and 1, 6-dihydropyrazine-2, 3-dicarbonitrile derivatives | |
Qin et al. | TBAI/TBHP catalyzed direct N-acylation of sulfoximines with aldehydes | |
CN108690007B (en) | C-H coupling reaction catalyzed by transition metal for efficiently preparing o-cyanoated aromatic ring or unsaturated aliphatic ring compound | |
CN108586376A (en) | A method of iodo benzoxazine is prepared by cuprous iodide | |
Cui et al. | The stable “F–SO2+” donor provides a mild and efficient approach to nitriles and amides | |
CN106045914A (en) | Method for synthesizing tri-substituted imidazole compounds | |
CN109400611B (en) | A kind of synthetic method of 1-vinyl-4,5-dihydropyrrole[1,2-a]quinoxaline compound | |
Raihan et al. | Halonium ion mediated synthesis of 2-halomethylene-3-oxoketoxime derivatives from isoxazoline N-oxides | |
CN102070503A (en) | Method for preparing pyrrole derivative | |
CN112125843B (en) | A kind of preparation method of 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinone compound | |
CN104327025B (en) | A kind of preparation method of 4-arylnaphthalene lactone derivative | |
CN104892499B (en) | A kind of synthetic method of 2 pyridinone derivatives | |
CN107573298A (en) | The preparation method of one kind 2,5 two substituted oxazoline compounds of synthesis | |
CN115197261A (en) | Synthesis method of oxadiazabenzboron derivative | |
CN102516162A (en) | Method for preparing copper-catalyzed nitro aromatic (heterocyclic) compounds | |
CN114195792A (en) | A kind of synthetic method of 1,2,3-triazole quinoxalinone derivatives | |
CN104710376A (en) | Method for synthesis of oxazoline derivative based on electrophilic iodocyclization reaction of propargylamide | |
CN104193667A (en) | Synthesis method of divergently oriented azacycles | |
CN104311495B (en) | Method for synthesizing NH-1,2,3-triazole | |
CN105566202B (en) | A kind of 1,2,3,4- tetrahydro cyclopentyl base indole derivatives and its synthetic method | |
CN117088826B (en) | Synthesis method of polysubstituted oxazole promoted by visible light | |
CN102603624B (en) | Preparation method of 2-pyridine carboxamide diaryl ketone compound as well as compound | |
CN103664917B (en) | A kind of 2-substituted isoxazoline or 2-replace the synthetic method of piperazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141119 Termination date: 20190125 |